How is HERZUMA administered? A Comprehensive Guide
•
3 min read
Approved in 2018 as a biosimilar to Herceptin, HERZUMA is a targeted therapy used to treat HER2-overexpressing cancers. Understanding how is HERZUMA administered is crucial for patients, as the intravenous infusion process involves specific protocols regarding administration timing and patient monitoring. The administration is a multi-step process performed by trained healthcare professionals in a controlled setting.
